Exploring metabolite profiling of patients with secondary progressive multiple sclerosis
http://discovery.ucl.ac.uk/10043414/1/M ... t%20al.pdf
Synopsis
Proton magnetic resonance spectroscopic imaging (MRSI) quantifies brain metabolism in vivo and has the potential of uncovering the mechanism of action of therapeutic drugs.
In this study, we assessed the baseline metabolic profile of 161 patients with secondary progressive multiple sclerosis (SPMS) against a control population by applying a short TE PRESS MRSI protocol at 3T.
Based on the results the SPMS population could be divided into different groups (normal/biochemically abnormal) suggesting biochemical heterogeneity within SPMS patients
several types of alterations in NAWM and NAGM
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1689 Views
-
Last post by frodo
-
- 0 Replies
- 1159 Views
-
Last post by frodo
-
- 0 Replies
- 1200 Views
-
Last post by frodo
-
- 0 Replies
- 2276 Views
-
Last post by frodo
-
- 0 Replies
- 1788 Views
-
Last post by frodo
-
- 2 Replies
- 1042 Views
-
Last post by frodo
-
- 0 Replies
- 1252 Views
-
Last post by frodo
-
- 0 Replies
- 1764 Views
-
Last post by frodo
-
- 1 Replies
- 1339 Views
-
Last post by frodo